We believe the vaccines are quite safe, with nearly 100,000 individuals participating in clinical trials thus far. Scientists throughout the world have been working nonstop, and in many cases collaboratively, to develop effective vaccines to protect people from COVID-19’s devastating effects. Pfizer’s vaccine is the first to receive approval. The trials and approval processes for the U.S., Canada, and the United Kingdom for this new vaccine have been robust, with multiple levels of reviews. A great deal is known about this drug, and while rare side effects can happen with any medication or vaccine, doctors and scientists believe that if those occur, they are likely to be mild and very rare.
This page was last updated on 2/5/2021.
Since the beginning of the pandemic, Touchmark has been steadfast in our commitment to keeping as many residents, team members, families, and partners as safe as possible. We care deeply about all who live and work in our communities and are adjusting to a new normal whenever things change.
We have created the below FAQ to make it easier for people to find the latest information about changes within our communities, as we work with national, state, and local health agencies and professionals to combat COVID-19.
The Full Life Continues
Touchmark Champions are team members who exemplify making smart decisions in all aspects of their lives to protect residents and their fellow team members.